404
Medical Marijuana Market Report
Global Medical Marijuana Market, Dynamics, Market Analysis
The report on the Global Medical Marijuana Market is segmented by Type (Buds, Oils, Tinctures), By Application (Chronic Pain, Mental Disorders, Cancer, Others), By End-User (Hospitals and Specialty Wound Care Clinics, Long Term Care Facilities, Home Healthcare), and Region. It also covers the COVID-19 Impact Analysis and Forecast to 2026.
This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global Medical Marijuana market. The historic years considered for the study are 2016-2019, the base year is 2020, the estimated year is 2021, and the forecast period is 2022-2026.
The medical marijuana market is expected to witness an impressive growth of 17% CAGR in the coming years.
Tilray (The U.S), Canopy Growth Corporation (Canada), Aurora Cannabis Inc. (Canada), Maricann Group Inc. (Canada), Aphria Inc. (Canada), Tikun Olam (Israel), GW Pharmaceuticals (UK), Cannabis Sativa (The U.S), Medical Marijuana, Inc. (The U.S) and MedReleaf Corp. (The U.S) are among the key players in the medical marijuana market.
The medical marijuana market size is expected to reach USD 53.0 billion in the foreseeable future.
North America accounted for the largest share of the medical marijuana market in 2020.
The cancer segment is expected to grow at the fastest CAGR in the medical marijuana market in the coming five years.
Increasing usage of medical marijuana in various medical applications including mental disorders, arthritis, chronic pain, and cancer among others, continuous investment in research and development activities to provide intervention for various diseases and symptoms are the factors driving the growth of medical marijuana market.
Medical marijuana distributors, Medical marijuana suppliers, Medical marijuana manufacturers, Logistics organizations, Government Bodies are the target audience in the medical marijuana market.